Immunotoxins directed against c-erbB-2(HER-2/neu) related surface antigens
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Jul 13, 2010
Grant Date -
Jul 28, 2005
app pub date -
Oct 13, 2004
filing date -
Apr 10, 1992
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
Novel immunotoxins and methods of treating neoplastic diseases are provided. More specifically, immunotoxins comprised conjugation of a c-erbB-2 targeting moiety and a cell growth modulator are provided. These immunotoxins specifically and selectively kill tumor cells that over-express the c-erbB-2 protein. The novel immunotoxins would be useful in treating human mammary carcinomas, human ovarian carcinomas, lung carcinomas, gastric tumors, salivary gland adenocarcinomas, and colon adenocarcinomas.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully